Prestige Consumer Healthcare (PBH) stock is soaring 5.31% in pre-market trading on Thursday following the release of its impressive fourth-quarter results and fiscal 2025 performance. The company reported better-than-expected earnings and revenue, demonstrating resilience in a challenging market environment.
For the fourth quarter, Prestige Consumer Healthcare posted adjusted earnings per share of $1.32, surpassing analysts' expectations of $1.30 and marking a significant increase from $1.02 in the same period last year. Revenue for the quarter reached $296.518 million, exceeding the estimated $289.4 million and showing growth from $277 million in the previous year. The company's gross profit for Q4 stood at $170.01 million, reflecting strong operational efficiency.
Looking ahead, Prestige Consumer Healthcare provided an optimistic outlook for fiscal 2026, projecting diluted earnings per share between $4.70 and $4.82 on revenue ranging from $1.14 billion to $1.16 billion. The company also anticipates organic growth of 1-2% for the fiscal year. However, it noted a potential $15 million headwind related to inflationary impacts from enacted tariffs, demonstrating its proactive approach to addressing market challenges.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.